EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Insulin Resistance and Oxidative Stress in a Mouse Model of Metabolic Syndrome following Twelve Weeks of Citrus Bioflavonoid Hesperidin Supplementation: A Dose–Response Study

Abdulsatar Jamal, Holly Brettle, Dina A Jamil, Vivian Tran, Henry Diep, Alexander Bobik, Chris van der Poel, Antony Vinh, Grant R Drummond, Colleen J Thomas iD, Maria Jelinic, Hayder A Al-Aubaidy iD

Biomolecules · 29.05.2024 · 14 (6) · 637

DOI: 10.3390/biom14060637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 29.05.2024. Verfasst von Abdulsatar Jamal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cardiovascular Biology and Disease Research, La Trobe Institute for Molecular Science (LIMS), & Department of Microbiology, Anatomy, Physi…. Hauptthemen laut MEDLINE: Hesperidin, Oxidative Stress, Insulin Resistance, Metabolic Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia (NHF) Postdoctoral Fellowship, National Health and Medical Research Council (NHMRC), La Trobe University internal start-up fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) is a cluster of metabolic abnormalities affecting ~25% of adults and is linked to chronic diseases such as cardiovascular disease, cancer, and neurodegenerative diseases. Oxidative stress and inflammation are key drivers of MetS. Hesperidin, a citrus bioflavonoid, has demonstrated antioxidant and anti-inflammatory properties; however, its effects on MetS are not fully established. We aimed to determine the optimal dose of hesperidin required to improve oxidative stress, systemic inflammation, and glycemic control in a novel mouse model of MetS. Male 5-week-old C57BL/6 mice were fed a high-fat, high-salt, high-sugar diet (HFSS; 42% kcal fat content in food and drinking water with 0.9% saline and 10% high fructose corn syrup) for 16 weeks. After 6 weeks of HFSS, mice were randomly allocated to either the placebo group or low- (70 mg/kg/day), mid- (140 mg/kg/day), or high-dose (280 mg/kg/day) hesperidin supplementation for 12 weeks. The HFSS diet induced significant metabolic disturbances. HFSS + placebo mice gained almost twice the weight of control mice (p < 0.0001). Fasting blood glucose (FBG) increased by 40% (p < 0.0001), plasma insulin by 100% (p < 0.05), and HOMA-IR by 150% (p < 0.0004), indicating insulin resistance. Hesperidin supplementation reduced plasma insulin by 40% at 140 mg/kg/day (p < 0.0001) and 50% at 280 mg/kg/day (p < 0.005). HOMA-IR decreased by 45% at both doses (p < 0.0001). Plasma hesperidin levels significantly increased in all hesperidin groups (p < 0.0001). Oxidative stress, measured by 8-OHdG, was increased by 40% in HFSS diet mice (p < 0.001) and reduced by 20% with all hesperidin doses (p < 0.005). In conclusion, hesperidin supplementation reduced insulin resistance and oxidative stress in HFSS-fed mice, demonstrating its dose-dependent therapeutic potential in MetS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HesperidinOxidative StressInsulin ResistanceMetabolic SyndromeCitrusMice, Inbred C57BLDietary SupplementsDisease Models, AnimalAnimalsMaleMiceDose-Response Relationship, DrugBlood GlucoseDiet, High-FatAntioxidants

Stichwörter der Autor:innen

8-hydroxydeoxyguanosineHbA1chesperidininsulinmetabolic syndrome

Substanzen

HesperidinBlood GlucoseAntioxidants

Autor:innen und Institutionen

  • Centre for Cardiovascular Biology and Disease Research, La Trobe Institute for Molecular Science (LIMS), & Department of Microbiology, Anatomy, Physiology & Pharmacology (MAPP), La Trobe University, Bundoora, VIC 3086,…
  • NewMed Education Australia, Hamilton, QLD 4007, Australia.
  • Baker Heart and Diabetes Research Institute, Melbourne, VIC 3004, Australia.
  • Australian Institute for Musculoskeletal Science, Melbourne, VIC 3021, Australia.
  • Pre-Clinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3052, Australia.

ORCID-Profile: Colleen J Thomas, Hayder A Al-Aubaidy

Förderung

  • National Heart Foundation of Australia (NHF) Postdoctoral Fellowship
  • National Health and Medical Research Council (NHMRC)
  • La Trobe University internal start-up fund
  • a Diabetes Australia Research Program General Grant
  • a joint National Health and Medical Research Council (NHMRC) and National Heart Foundation of Australia (NHF) Postdoctoral Fellowship
  • Australian Research Training Scholarship

Zitieren

APA

Jamal, A., Brettle, H., Jamil, D. A., Tran, V., Diep, H., Bobik, A., van der Poel, C., Vinh, A., Drummond, G. R., Thomas, C. J., Jelinic, M., & Al-Aubaidy, H. A. (2024). Reduced Insulin Resistance and Oxidative Stress in a Mouse Model of Metabolic Syndrome following Twelve Weeks of Citrus Bioflavonoid Hesperidin Supplementation: A Dose–Response Study. Biomolecules, 14(6), 637. https://doi.org/10.3390/biom14060637

Vancouver

Jamal A, Brettle H, Jamil DA, Tran V, Diep H, Bobik A, et al. Reduced Insulin Resistance and Oxidative Stress in a Mouse Model of Metabolic Syndrome following Twelve Weeks of Citrus Bioflavonoid Hesperidin Supplementation: A Dose–Response Study. Biomolecules. 2024;14(6):637. doi:10.3390/biom14060637

BibTeX
@article{Jamal2024,
  author = {Jamal, Abdulsatar and Brettle, Holly and Jamil, Dina A and Tran, Vivian and Diep, Henry and Bobik, Alexander and van der Poel, Chris and Vinh, Antony and Drummond, Grant R and Thomas, Colleen J and Jelinic, Maria and Al-Aubaidy, Hayder A},
  title = {Reduced Insulin Resistance and Oxidative Stress in a Mouse Model of Metabolic Syndrome following Twelve Weeks of Citrus Bioflavonoid Hesperidin Supplementation: A Dose–Response Study},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {6},
  pages = {637},
  doi = {10.3390/biom14060637}
}
Kostenlos starten →